This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Keyton Weissinger (Photo: Business Wire)

Standard Register Healthcare, a business unit of Standard Register (NYSE: SR) and a leader in managing critical communications for healthcare, has promoted Keyton Weissinger to the newly created position of vice president of innovation in which his first priority will be enhancing efforts to bring new solutions to market that drive patient engagement.

Keyton Weissinger (Photo: Business Wire)

Keyton Weissinger (Photo: Business Wire)

“Legislative initiatives have made patient engagement a central focus for providers and payers,” said John King, president of Standard Register Healthcare. “Keyton brings the energy, vision and experience that are vital to developing patient-centric communication tools to engage patients more fully and effectively in their care.”

A self-described evangelist for healthcare transformation, Weissinger is a 20-year veteran of information technology with 10 years of experience in healthcare at both large corporations and entrepreneurial startups.

Prior to this promotion, he was vice president of technical operations for Dialog Medical, which Standard Register acquired in 2010. There, he was responsible for the management and day-to-day leadership of software development, implementation and customer service. He led the development of the iMedConsent™ application, a robust patient engagement solution that supports informed consent, discharge and patient education.

Originally a software developer, he went on to hold management positions at Arthur Andersen Business Consulting and a hospitality startup which took property management to the cloud for the first time.

Weissinger is author of dozens of scholarly articles and two technology books, including one that was published internationally in eight languages. He regularly shares his insights on Twitter @PatientEngaged.

Weissinger will be participating at the Strategic Partner Forum at HIMSS13 in New Orleans on March 3.

About Standard RegisterStandard Register (NYSE:SR), celebrating 100 years of innovation, is trusted by the world’s leading companies to advance their reputations by aligning their communications with corporate standards and priorities. Providing market-specific insights and a compelling portfolio of solutions to address the changing business landscape in commercial, healthcare, financial services and industrial markets, Standard Register is the recognized leader in the management and execution of mission-critical communications. More information is available at www.standardregister.com.

Standard Register Healthcare is a business unit of Standard Register, serving more than 3,100 clients from across the healthcare delivery network, including acute, ambulatory, and long-term care, managed care and the suppliers that support them. A recognized leader in managing critical information and communications, Standard Register Healthcare, together with Dialog Medical, a subsidiary of Standard Register, provides industry-leading technology, solutions and services to accelerate performance, attract and educate patients, enhance safety and support patient-centered care. More information is available at www.standardregister.com/healthcare.

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20130221005201/en/

Copyright Business Wire 2010

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,156.85 +24.88 0.15%
S&P 500 2,001.57 +2.59 0.13%
NASDAQ 4,562.1890 +9.43 0.21%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs